Mashup Score: 54
ScienceDirectVenetoclax is a highly selective B-cell lymphoma-2 (BCL-2) inhibitor, which, combined with a DNA hypomethylating agent or low dose cytarabine,
Mashup Score: 54
ScienceDirectVenetoclax is a highly selective B-cell lymphoma-2 (BCL-2) inhibitor, which, combined with a DNA hypomethylating agent or low dose cytarabine,
Acute myeloid leukemia resistant to venetoclax-based therapy: What doe... https://t.co/0ETlqswB5t - view on twitter
RT @smbenlazar: Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold? https://t.co/zOtvKKPNIy #AML #leus… - view on twitter